Catalyst Pharmaceuticals, Inc. logo CPRX - Catalyst Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 13
HOLD 3
SELL 0
STRONG
SELL 0
| PRICE TARGET: $32.00 DETAILS
HIGH: $32.00
LOW: $32.00
MEDIAN: $32.00
CONSENSUS: $32.00
UPSIDE: 2.37%

Profitability Ratios

Ratio Value
GP Margin 85.2%
EBIT Margin 43.8%
EBITDA Margin 50.2%
Operating Margin 43.8%
Pretax Margin 48.1%
Cont. Ops Margin 36.4%
Net Margin 36.4%
Bottom Line Margin 36.4%

Liquidity Ratios

Ratio Value
Current Ratio 6.08
Quick Ratio 5.82
Solvency Ratio 1.653
Cash Ratio 4.82

Valuation Ratios

Ratio Value
Price/Earnings
13.32
Hist. avg: 15.9
Peers avg: 27.0
PEG Ratio 0.50
Forward PEG 0.50
Price/Book 2.99
Price/Sales 4.85
Price/FCF 13.68
Price/Op Cash Flow 13.68

Debt Ratios

Ratio Value
Debt/Assets 0.0025
Debt/Equity 0.0029
Debt/Capital 0.0029
Long-Term Debt/Capital 0.0000
Financial Leverage 1.16

Cash Flow Ratios

Ratio Value
Working Capital Turnover 0.94
Operating Cash Flow Ratio 1.418
Operating Cash Flow/Sales 35.4%
Free Cash Flow/Operating Cash Flow 100.0%

Coverage Ratios

Ratio Value
Debt Service Coverage 518.22
Interest Coverage 0.0000
Short-Term Operating Cash Flow Coverage 477.51
Operating Cash Flow Coverage 74.87
Capital Expenditure Coverage 3597.76
Dividend + Capital Expenditure Coverage 3597.76

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 4.82
EPS 1.753
Debt/Share 0.0228
Cash/Share 5.80
Book Value/Share 7.80
Tangible BV/Share 6.73
Equity/Share 7.80
Operating Cash Flow/Share 1.706
Capital Expenditure/Share 0.000
FCF/Share 1.706

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.756
Earnings Before Tax/EBIT 1.100
Price/Fair Value 2.99
Debt/Market Cap 0.0002
Effective Tax Rate 24.4%
Enterprise Value Multiple 7.26